Search
for
Sort by
Research 661–690 of 876
- The biodisposition and hypertrichotic effects of bimatoprost in mouse skin
- Demodicosis of Ophthalmic Concern
- 1017 The prostaglandin F2α analog bimatoprost activates secondary hair germ cells to promote hair growth through two distinct signaling pathways
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Alopecia Areata
- The prostamide‐related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias
- Keratin expression by corneal and limbal stem cells during development
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Baricitinib: A Review in Severe Alopecia Areata
- Clinical Snippets
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Bimatoprost
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial
- Alopecia Universalis Successfully Treated With Adalimumab
- A retrospective analysis of efficacy and safety of intralesional triamcinolone injections in the treatment of frontal fibrosing alopecia either as monotherapy or as a concomitant therapy
- Clinical Description of Frontal Fibrosing Alopecia with Concomitant Lichen Planopilaris
- Hair changes due to zinc deficiency in a case of sucrose malabsorption
- Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Periocular Manifestations of Afatinib Therapy
- Frontal fibrosing alopecia in men: A multicenter study of 39 patients
- Loose anchoring of anagen hairs and pili torti due to erlotinib
- Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- A case report of alopecia totalis associated with permanent hair dye use
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Lasers, lights, and compounds for hair loss in aesthetics